Lipids are a form of fat that serves as an important structural component of the body's cell walls. Lipids are also stored in tissues and are broken down when the body can no longer utilize glucose. An example of this occurrence is when one...
Miglustat is a drug developed by Actelion and is used primarily to treat Type 1 Gaucher disease (GD1). It is marketed under the trade name Zavesca. Miglustat (OGT 918 ...
Miglustat is used to treat Gaucher disease (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in ...
Miglustat is used to treat Gaucher disease (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in ...
All about Miglustat. View complete and up to date Miglustat information - part of the Drugs.com trusted medication database.
Official product website with information for consumers and health professionals.
1. Lancet Neurol. 2007 Sep;6(9):765-72. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Patterson MC, Vecchio D, Prady H, Abel L ...
ZAVESCA - miglustat capsule Actelion Pharmaceuticals US, Inc.-----ZAVESCA ® [miglustat] Capsules, 100mg. PACKAGE INSERT. DESCRIPTION. ZAVESCA ® (miglustat capsules ...
Miglustat may reduce the formation of the protein glucosylceramide in the body. Individuals with type 1 Gaucher disease a hereditary disorder are mi
Miglustat is a prescription drug used in the treatment of type 1 Gaucher disease, which is a hereditary disorder characterized by the accumulation of a protein called ...
Learn about the prescription medication Zavesca (Miglustat), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
